‘Communal forces adopting ‘guerilla’ techniques to disrupt peace’

Dubai, Jul 9: Air India Express has opened ticket bookings for flights from India to the UAE from July 12 to 26. The carrier posted the announcement on its social media pages.

“INDIA to UAE - Flights are open for sale! Bookings could be made through our website (http://airindiaexpress.in), call centre or authorised travel agents. Visit http://blog.airindiaexpress.in for more details,” the budget airline tweeted.

A clause mentioned in the flyer attached to the post added that only UAE residents with permits to return from India can book flights.

Thousands of Indian expats have been waiting to book flights back to the UAE after being stuck home for about four months due to the COVID-19 travel restrictions.

Vande Bharat Mission flights

Under the fourth phase of Vande Bharat Mission, as many as 104 flights will be operating between UAE and India. 

The Air India announced this on Twitter under a post “#FlyAI : Important Information for ICA approved UAE residents who wish to travel to UAE on Vande Bharat Mission flights.”

A flyer attached to the post addressed passengers who wish to travel to UAE on flights being operated under Vande Bharat Mission by Air India and Air India Express in pursuance of agreement between Civil Aviation authorities of India and the UAE.

“AI and AIE operating evacuation flights to Indian citizens from the UAE to India will carry ICA approved UAE residents (returning to the UAE from India) on the outward journey from India to the UAE.”

“On the India-UAE journey, all these flights will carry only those passengers who are destined for the UAE.”

“This arrangement will be operational for a period of 15 days from July 12 to 26,” the airline added.

While most of the Vande Bharat flights are operated by AIE, a few flights from Sharjah are operated by Air India.

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.

In a shocking incident, a pharmacist-cum-production manager of an Ayurvedic product company in Chennai’s T.Nagar died after drinking a chemical preparation he reportedly formulated for tackling the Coronavirus.

The managing director of the company, who is an ophthamologist by qualification, was hospitalised after he fainted soon after he ingested the chemical component.

The deceased, K.Sivanesan, 47, of Perungudi, was with Chennai-based Sujatha Biotech, an Ayurvedic and herbal products company which was founded 30 years ago. It has a plant in Kashipur, Uttarakhand, where Sivanesan was working. Sivanesan had devised formulas of various products and used to visit his managing director Dr. Rajkumar frequently in the city.

Due to the lockdown, Sivanesan came to Chennai and stayed with his family in Perungudi. On Thursday morning, he procured the chemical component from a market in Parry’s Corner.

First he gave a small amount powder he derived from the chemical to 67 years-old Rajkumar who fainted after tasting it.

Even as he was being resuscitated, Sivanesan went into the kitchen of the house and gulped it in liquid form after adding water to it. He could not be revived.

Deputy Commissioner of Police, T.Nagar, Ashok Kumar, said, “Our investigation revealed that Sivanesan died after drinking the preparation he claimed would help COVID-19 patients. His managing director fainted after tasting it initially. Further investigation is on.”

Sivanesan was rushed to a private hospital in T.Nagar and declared dead by the doctors there. Later his body was shifted to Government Royapettah Hospital for post-mortem. Teynampet police registered a case under section 174 of Criminal Procedure Code for unnatural death.

N.S.Vasan, designer-cum-media manager of the company said, “Due to the lockdown, Sivanesan stayed in the city and one day told us he heard of some medicine from U.S. President Donald Trump’s recent speech for curing Coronavirus. He said it would bring more immunity and help to prevent COVID-19. Deciding to test the effect of the medicine, he went to Parry’s Corner and bought the powder.” He added that Sivanesan must have taken a heavy dosage of the ‘drug’ and he was killed instantly.